Pathophysiology and treatment of stroke in sickle-cell disease: present and future
- 1 June 2006
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 5 (6) , 501-512
- https://doi.org/10.1016/s1474-4422(06)70469-0
Abstract
No abstract availableKeywords
This publication has 139 references indexed in Scilit:
- Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomyThe Journal of Pediatrics, 2004
- Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial strokeThe Journal of Pediatrics, 2002
- Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusionsThe Journal of Pediatrics, 1995
- Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytesAmerican Heart Journal, 1993
- Stroke in a cohort of patients with homozygous sickle cell diseaseThe Journal of Pediatrics, 1992
- Diagnosis of cerebrovascular disease in sickle cell anemia by magnetic resonance angiographyThe Journal of Pediatrics, 1990
- Detection of cerebral vasculopathy in sickle cell disease using transcranial Doppler ultrasonography and magnetic resonance imaging. Case report.Stroke, 1988
- Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography.Stroke, 1986
- Erythrocyte Adherence to Endothelium in Sickle-Cell AnemiaNew England Journal of Medicine, 1980
- Transfusion therapy for cerebrovascular abnormalities in sickle cell diseaseThe Journal of Pediatrics, 1976